NRC Health (NRC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $563.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
NRC Health (NRC) Stock Forecast
Analysts expect NRC Health (NRC) to earn $0.39 per share in the fiscal year ending Dec 31, 2026, on revenue of $147.40M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.06.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 171.8% and revenue estimates rise 5.2%.
- Fiscal year ending Dec 31, 2026
- $0.39
- EPS consensus, revenue $147.40M
- Fiscal year ending Dec 31, 2027
- $1.06
- EPS consensus, revenue $155.00M
- Next report
- Feb 1, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.39 | $0.39 to $0.39 | 1 | $147.40M | $147.40M to $147.40M | 1 |
| Dec 31, 2027 | $1.06 | $1.06 to $1.06 | 1 | $155.00M | $155.00M to $155.00M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $0.23 | $0.23 to $0.23 | 1 | $37.20M | $37.20M to $37.20M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 18.2% from $0.33.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.39 | $0.33 | $0.33 | $0.33 | $0.33 | +18.2% |
| Fiscal year ending Dec 31, 2027 | $1.06 | $1.05 | $1.05 | $1.05 | $1.05 | +1.0% |
| Quarter ending Mar 31, 2027 | $0.23 | $0.24 | $0.24 | $0.24 | $0.24 | -4.2% |
Frequently Asked Questions About NRC
What is the NRC stock forecast?
Consensus analyst estimates put NRC Health's EPS at $0.39 for the fiscal year ending Dec 31, 2026, on revenue of $147.40M.
What EPS do analysts expect from NRC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.39, with estimates from $0.39 to $0.39 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.06, with estimates from $1.06 to $1.06 from 1 analyst.
What revenue do analysts expect from NRC Health next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $147.40M, with estimates from $147.40M to $147.40M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $155.00M, with estimates from $155.00M to $155.00M.
How many analysts cover NRC?
1 analyst estimates EPS for NRC Health for the fiscal year ending Dec 31, 2026.
NRC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors